Cargando…

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

The combination of Cas9, guide RNA and repair template DNA can induce precise gene editing and the correction of genetic diseases in adult mammals. However, clinical implementation of this technology requires safe and effective delivery of all of these components into the nuclei of the target tissue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Hao, Song, Chun-Qing, Dorkin, Joseph R, Zhu, Lihua J, Li, Yingxiang, Wu, Qiongqiong, Park, Angela, Yang, Junghoon, Suresh, Sneha, Bizhanova, Aizhan, Gupta, Ankit, Bolukbasi, Mehmet F, Walsh, Stephen, Bogorad, Roman L, Gao, Guangping, Weng, Zhiping, Dong, Yizhou, Koteliansky, Victor, Wolfe, Scot A, Langer, Robert, Xue, Wen, Anderson, Daniel G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423356/ https://www.ncbi.nlm.nih.gov/pubmed/26829318 http://dx.doi.org/10.1038/nbt.3471

Ejemplares similares

A versatile reporter system for CRISPR-mediated chromosomal rearrangements
por: Li, Yingxiang, et al.
Publicado: (2015)

Orthogonal Cas9–Cas9 chimeras provide a versatile platform for genome editing
por: Bolukbasi, Mehmet Fatih, et al.
Publicado: (2018)

Publisher Correction: Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing
por: Bolukbasi, Mehmet Fatih, et al.
Publicado: (2018)

Enhanced Cas12a editing in mammalian cells and zebrafish
por: Liu, Pengpeng, et al.
Publicado: (2019)

Packaging and Uncoating of CRISPR/Cas Ribonucleoproteins for Efficient Gene Editing with Viral and Non-Viral Extracellular Nanoparticles
por: Mazurov, Dmitriy, et al.
Publicado: (2023)

Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections
por: Najafi, Sajad, et al.
Publicado: (2022)

Self-delivering CRISPR RNAs for AAV Co-delivery and Genome Editing in vivo
por: Zhang, Han, et al.
Publicado: (2023)

CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion
por: Mou, Haiwei, et al.
Publicado: (2017)

GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases
por: Zhu, Lihua Julie, et al.
Publicado: (2017)

Genome-wide detection of CRISPR editing in vivo using GUIDE-tag
por: Liang, Shun-Qing, et al.
Publicado: (2022)

Viral Delivery Systems for CRISPR
por: Xu, Christine L., et al.
Publicado: (2019)

Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9
por: Chou, Yi-ying, et al.
Publicado: (2016)

Polyethylenimine based magnetic nanoparticles mediated non-viral CRISPR/Cas9 system for genome editing
por: Rohiwal, S. S., et al.
Publicado: (2020)

Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9
por: Oh, Hyung Suk, et al.
Publicado: (2019)

DNA-binding domain fusions enhance the targeting range and precision of Cas9
por: Bolukbasi, Mehmet Fatih, et al.
Publicado: (2015)

CRISPR Tackles Emerging Viral Pathogens
por: Kirby, Emily N., et al.
Publicado: (2021)

An MHV-68 Mutator Phenotype Mutant Virus, Confirmed by CRISPR/Cas9-Mediated Gene Editing of the Viral DNA Polymerase Gene, Shows Reduced Viral Fitness
por: Trompet, Erika, et al.
Publicado: (2021)

A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape
por: Lebbink, Robert Jan, et al.
Publicado: (2017)

Intra-embryo Gene Cassette Knockin by CRISPR/Cas9-Mediated Genome Editing with Adeno-Associated Viral Vector
por: Mizuno, Naoaki, et al.
Publicado: (2018)

Mapping the coevolution, leadership and financing of research on viral vectors, RNAi, CRISPR/Cas9 and other genomic editing technologies
por: Fajardo-Ortiz, David, et al.
Publicado: (2020)

Non-viral ex vivo genome-editing in mouse bona fide hematopoietic stem cells with CRISPR/Cas9
por: Byambaa, Suvd, et al.
Publicado: (2021)

Non-viral delivery of CRISPR–Cas9 complexes for targeted gene editing via a polymer delivery system
por: O’Keeffe Ahern, Jonathan, et al.
Publicado: (2021)

Review: Sustainable Clinical Development of CAR-T Cells – Switching From Viral Transduction Towards CRISPR-Cas Gene Editing
por: Wagner, Dimitrios L., et al.
Publicado: (2022)

CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors
por: Leal, Andrés Felipe, et al.
Publicado: (2022)

CRISPR-Cas9-based non-viral gene editing therapy for topical treatment of recessive dystrophic epidermolysis bullosa
por: Wang, Xianqing, et al.
Publicado: (2023)

Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape
por: White, Martyn K., et al.
Publicado: (2016)

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
por: Ramanan, Vyas, et al.
Publicado: (2015)

Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing
por: Chiou, Shin-Heng, et al.
Publicado: (2015)

CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice
por: Dash, Prasanta K., et al.
Publicado: (2023)

Synthetic Oligonucleotides Inhibit CRISPR-Cpf1-Mediated Genome Editing
por: Li, Bin, et al.
Publicado: (2018)

Therapeutic Application of Genome Editing Technologies in Viral Diseases
por: Kim, Tae Hyeong, et al.
Publicado: (2022)

CRISPR/Cas9-mediated viral interference in plants
por: Ali, Zahir, et al.
Publicado: (2015)

Immune Responses to Gene Editing by Viral and Non-Viral Delivery Vectors Used in Retinal Gene Therapy
por: Ren, Duohao, et al.
Publicado: (2022)

Cell specific single viral vector CRISPR/Cas9 editing and genetically encoded tool delivery in the central and peripheral nervous systems
por: Moffa, Jamie C., et al.
Publicado: (2023)

A viral ring nuclease anti-CRISPR subverts type III CRISPR immunity
por: Athukoralage, Januka S, et al.
Publicado: (2020)

Viral Infections of Humans. Epidemiology and Control. 3rd Edition
por: Jenson, Hal B.
Publicado: (1990)

The emerging role of viral vectors as vehicles for DMD gene editing
por: Maggio, Ignazio, et al.
Publicado: (2016)

Inhibition of Caspases Improves Non-Viral T Cell Receptor Editing
por: Wang, Chunxi, et al.
Publicado: (2020)

Genome editing in archaeal viruses and endogenous viral protein purification
por: Alfastsen, Lauge, et al.
Publicado: (2021)

Genome Editing Technologies as Cellular Defense Against Viral Pathogens
por: Zhang, Yingzi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_55ushnjig9n0js88plhb4gdpkj